PressDigest

LDC nears £100m takeover of UK clinical trials firm

Private equity firm Lyceum Capital is nearing a sale of Synexus, a UK clinical trials specialist it acquired for £18m in 2007, to peer LDC for £100m.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump